| 96 | 2 | 56 |
| 下载次数 | 被引频次 | 阅读次数 |
目的：评价疏肝和胃中药联合穴位敷贴治疗肝胃郁热型非糜烂性反流病的疗效。方法：将70例肝胃郁热型非糜烂性反流病(NERD)患者按照随机分组方式，分为中药组和西药组，每组各35例。中药组给予疏肝和胃法联合穴位敷贴，西药组给予雷贝拉唑治疗，疗程8周，比较两组患者的临床疗效、精神心理及生活质量的改善情况。结果：中药组、西药组总有效率分别为94.29%和85.71%,两组疗效有统计学差异(P<0.05)。两组治疗后症状积分、焦虑及抑郁评分均较前下降，健康状况总分均较前升高(均P<0.05);且治疗后中药组上述指标均明显优于西药组(均P<0.05)。结论：疏肝和胃法联合穴位敷贴治疗NERD患者在改善临床症状、缓解焦虑抑郁情绪、提高生活质量上优于雷贝拉唑。
Abstract：Objective: To evaluate the efficacy of Shugan hewei decoction combined with acupoint application in the treatment of non-erosive reflux disease(NERD) caused by stagnant heat in the liver and stomach.Methods: A total of 70 cases with NERD were randomly divided into the traditional Chinese medicine group and the Western medicine group, with 35 cases in each group. Patients in the traditional Chinese medicine group were treated with Shugan hewei decoction and acupoint application, while the Western medicine group were treated with rabeprazole. The course of treatment was 8 weeks. The clinical efficacy, mental and psychological status, as well as life quality of the two groups were compared. Results: The total effective rate of the traditional Chinese medicine group was 94.29%, which was statistically higher than the Western medicine group of 85.71%(P<0.05). The symptom scores, anxiety and depression scores were decreased, while overall health scores were increased significantly after treatment, both in two groups(all P<0.05). Moreover, the above indicators were improved better in the traditional Chinese medicine group than these in the Western medicine group(all P<0.05). Conclusion: The combination of Shugan hewei decoction and acupoint application is better than rabeprazole in improving clinical symptoms, relieving anxiety and depression, and enhancing the life quality of NERD patients.
[1] Jurkiewicz D,Wasko-Czopnik D,Pietruszewska W,et al.Gastroesophageal reflux disease-from the point of view of a gastroenterologist,otolaryngologist and surgeon[J].Otolaryngol Pol,2021,75(2):42-50.
[2] Chen S,Du F,Zhong C Q,et al.Gastroesophageal reflux disease:recent innovations in endoscopic assessment and treatment[J].Gastroenterol Rep (Oxf),2021,9(5):383-391.
[3] 磨勇，梁光春，陈静，等.470例胃食管反流病的临床流行病学研究[J].中国医药科学，2011,1(16):38.
[4] 陈旻湖，侯晓华，肖英莲，等.2014年中国胃食管反流病专家共识意见[J].胃肠病学，2015,20(3):155-168.
[5] Savarino V,Marabotto E,Zentilin P,et al.Pharmacological management of gastro-esophageal reflux disease:an update of the state-of-the-art[J].Drug Des Devel Ther,2021,15:1609-1621.
[6] 魏秀秀，张北华，尹晓岚，等.胃食管反流病的中西医治疗现状述评[J].世界中医药，2022,17(15):2101-2107.
[7] 张声生，朱生樑，王宏伟，等.胃食管反流病中医诊疗专家共识意见(2017)[J].中国中西医结合消化杂志，2017,25(5):321-326.
[8] 段泉泉，胜利.焦虑及抑郁自评量表的临床效度[J].中国心理卫生杂志，2012,26(9):676-679.
[9] 李春波，何燕玲.健康状况调查问卷SF-36的介绍[J].国外医学(精神病学分册),2002,29(2):116-119.
[10] Katzka D A,Pandolfino J E,Kahrilas P J.Phenotypes of gastroesophageal reflux disease:where Rome,Lyon,and Montreal meet[J].Clin Gastroenterol Hepatol,2020,18(4):767-776.
[11] 简晓敏，张璐，邹忠杰，等.基于UPLC-QTOF-MS技术的左金丸治疗大鼠胃热证的血清代谢组学研究[J].中药新药与临床药理，2022,33(7):870-875.
[12] 崔亚，邓海鹏，焦黛妍.六君子汤合旋覆代赭汤治疗反流性食管炎临床疗效及对HIF-2α/NF-κB信号通路的影响[J].辽宁中医杂志，2023,50(1):58-62.
[13] 李力恒，陈丽萍，胡晓阳，等.柴胡的化学成分及药理作用研究进展[J].中医药学报，2023,51(2):109-112.
[14] 李迪，姚建平.柴胡配伍调控CREB治疗抑郁症研究进展[J].光明中医，2022,37(16):2925-2929.
[15] 林霏霏，黄文英.氟哌噻吨美利曲辛对伴有焦虑抑郁非糜烂性胃食管反流病的治疗效果及药学分析[J].临床合理用药杂志，2020,13(20):58-60.
[16] Wong M W,Liu T T,Yi C H,et al.Oesophageal hypervigilance and visceral anxiety relate to reflux symptom severity and psychological distress but not to acid reflux parameters[J].Aliment Pharmacol Ther,2021,54(7):923-930.
[17] 刘德龙，卢光新.文拉法辛与黛力新对难治性非糜烂性胃食管反流病患者的临床对照研究[J].中国医学工程，2022,30(5):73-76.
基本信息:
中图分类号:R259
引用信息:
[1]张宇,赵颖.疏肝和胃法联合穴位敷贴治疗肝胃郁热型非糜烂性反流病临床观察[J].巴楚医学,2023,6(02):78-82.
基金信息:
上海市浦东新区光明中医医院院内科技基金项目(No:Gmzyms-201909)
2023-06-30
2023-06-30